Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2016-11-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.02130-16PMID 27855077PMCID PMC5278697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• University of Groningen Characterization of a phenylacetate-CoA ligase from Penicillium chrysogenum

  2017cited by this paper
• Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.

  2016influential reference
• High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis

  2016cited by this paper
• Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis

  2015cited by this paper
• Giardia fatty acyl-CoA synthetases as potential drug targets

  2015cited by this paper
• Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.

  2015cited by this paper
• Mycobacterium tuberculosis possesses an unusual tmRNA rescue system.

  2014cited by this paper
• Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

  2014cited by this paper
• The pyrazinamide susceptibility breakpoint above which combination therapy fails

  2014cited by this paper
• Specialized Transduction Designed for Precise High-Throughput Unmarked Deletions in Mycobacterium tuberculosis

  2014cited by this paper
• Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide

  2014cited by this paper
• Cyclic AMP-dependent Protein Lysine Acylation in Mycobacteria Regulates Fatty Acid and Propionate Metabolism*

  2013cited by this paper
• Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis

  2011cited by this paper
• Multiple FadD Acyl-CoA Synthetases Contribute to Differential Fatty Acid Degradation and Virulence in Pseudomonas aeruginosa

  2010cited by this paper
• Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing Strategy

  2010cited by this paper
• NAD+ auxotrophy is bacteriocidal for the tubercle bacilli

  2010cited by this paper
• Characterization of a phenylacetate-CoA ligase from Penicillium chrysogenum.

  2009cited by this paper
• Hepatotoxicity of pyrazinamide: cohort and case-control analyses.

  2008cited by this paper
• Nutrient-Starved Incubation Conditions Enhance Pyrazinamide Activity against Mycobacterium tuberculosis

  2007cited by this paper
• Nutrient-starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

  2007cited by this paper
• Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis

  2007cited by this paper
• Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria

  2004cited by this paper
• Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

  2004cited by this paper
• Identification of a Regulated Alkaline Phosphatase, a Cell Surface-Associated Lipoprotein, in Mycobacterium smegmatis

  2003cited by this paper
• Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.

  2003cited by this paper
• Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis.

  2002cited by this paper
• Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I

  2002cited by this paper
• Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

  2000cited by this paper
• In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria.

  1999cited by this paper
• Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

  1997cited by this paper
• Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibility

  1996cited by this paper
• Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

  1996influential reference
• Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide

  1995cited by this paper
• Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.

  1987cited by this paper
• [The hepatotoxicity of pyrazinamide].

  1984cited by this paper
• Mycobacterium

  1977cited by this paper
• Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

  1967influential reference
• Tissue sulfhydryl groups.

  1959cited by this paper
• Bacteriology of tuberculosis: laboratory methods.

  1958cited by this paper
• Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

  1954cited by this paper

• The long chain fatty acid-CoA ligase VraA plays a regulatory role in vancomycin resistance in Staphylococcus aureus.

  2025cites this paper
• Functional and Mechanistic Insights into the Fatty-Acid CoA Ligase FadK in Escherichia coli.

  2025cites this paper
• Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus

  2024cites this paper
• Targeting Mycobacterium tuberculosis pH-driven adaptation

  2024cites this paper
• Mechanism of the dual action self-potentiating antitubercular drug morphazinamide

  2024cites this paper
• Recombinant expression and functional characterization of FadD2 protein in Mycobacterium tuberculosis.

  2023cites this paper
• Comparative proteomic investigation unravels the pathobiology of Mycobacterium fortuitum biofilm

  2023cites this paper
• Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis

  2022cites this paper
• Targeting the Bet-Hedging Strategy with an Inhibitor of Bacterial Efflux Capacity Enhances Antibiotic Efficiency and Ameliorates Bacterial Persistence In Vitro

  2022influential citation
• Mycobacterium tuberculosis Requires the Outer Membrane Lipid Phthiocerol Dimycocerosate for Starvation-Induced Antibiotic Tolerance

  2022cites this paper
• Differentially expressed genes in Mythimna separata under chlorantraniliprole exposure and functional identification

  2022cites this paper
• Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics

  2021cites this paper
• Pyrazinamide action is driven by the cell envelope stress response in Mycobacterium tuberculosis

  2021cites this paper
• Expression of fatty acyl-CoA ligase drives one-pot de novo synthesis of membrane-bound vesicles in a cell free transcription-translation system

  2021cites this paper
• Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance

  2020cites this paper
• The Acid-Base Equilibrium of Pyrazinoic Acid Drives the pH Dependence of Pyrazinamide-Induced Mycobacterium tuberculosis Growth Inhibition.

  2020cites this paper
• The Bewildering Antitubercular Action of Pyrazinamide

  2020cites this paper
• Impact of the host environment on the antitubercular action of pyrazinamide

  2019cites this paper
• Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.

  2019cites this paper
• Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH.

  2019cites this paper
• Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis

  2019cites this paper
• In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1

  2017cites this paper
• Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA

  2017cites this paper
• Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.

  2017cites this paper
• Mycobacterium smegmatis PhoU Proteins Have Overlapping Functions in Phosphate Signaling and Are Essential

  2017cites this paper